Kosaka T - Search Results

1

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Jänne PA. Engelman JA, et al. Among authors: kosaka t. Science. 2007 May 18;316(5827):1039-43. doi: 10.1126/science.1141478. Epub 2007 Apr 26. Science. 2007. PMID: 17463250

2

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Kosaka T, et al. Cancer Res. 2004 Dec 15;64(24):8919-23. doi: 10.1158/0008-5472.CAN-04-2818. Cancer Res. 2004. PMID: 15604253

3

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.

Mitsudomi T, Kosaka T, Endoh H, Horio Y, Hida T, Mori S, Hatooka S, Shinoda M, Takahashi T, Yatabe Y. Mitsudomi T, et al. Among authors: kosaka t. J Clin Oncol. 2005 Apr 10;23(11):2513-20. doi: 10.1200/JCO.2005.00.992. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738541 Clinical Trial.

4

EGFR mutation is specific for terminal respiratory unit type adenocarcinoma.

Yatabe Y, Kosaka T, Takahashi T, Mitsudomi T. Yatabe Y, et al. Among authors: kosaka t. Am J Surg Pathol. 2005 May;29(5):633-9. doi: 10.1097/01.pas.0000157935.28066.35. Am J Surg Pathol. 2005. PMID: 15832087

5

[Translational research on lung cancer--EGFR gene mutation].

Kosaka T, Endoh H, Yatabe Y, Mitsudomi T. Kosaka T, et al. Gan To Kagaku Ryoho. 2005 Jun;32(6):750-8. Gan To Kagaku Ryoho. 2005. PMID: 15984511 Review. Japanese.

6

EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib.

Shimato S, Mitsudomi T, Kosaka T, Yatabe Y, Wakabayashi T, Mizuno M, Nakahara N, Hatano H, Natsume A, Ishii D, Yoshida J. Shimato S, et al. Among authors: kosaka t. Neuro Oncol. 2006 Apr;8(2):137-44. doi: 10.1215/15228517-2005-002. Epub 2006 Jan 20. Neuro Oncol. 2006. PMID: 16510849 Free PMC article.

7

Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.

Takeuchi T, Tomida S, Yatabe Y, Kosaka T, Osada H, Yanagisawa K, Mitsudomi T, Takahashi T. Takeuchi T, et al. Among authors: kosaka t. J Clin Oncol. 2006 Apr 10;24(11):1679-88. doi: 10.1200/JCO.2005.03.8224. Epub 2006 Mar 20. J Clin Oncol. 2006. PMID: 16549822

8

A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer.

Yatabe Y, Hida T, Horio Y, Kosaka T, Takahashi T, Mitsudomi T. Yatabe Y, et al. Among authors: kosaka t. J Mol Diagn. 2006 Jul;8(3):335-41. doi: 10.2353/jmoldx.2006.050104. J Mol Diagn. 2006. PMID: 16825506 Free PMC article.

9

Biological and clinical implications of EGFR mutations in lung cancer.

Mitsudomi T, Kosaka T, Yatabe Y. Mitsudomi T, et al. Among authors: kosaka t. Int J Clin Oncol. 2006 Jun;11(3):190-8. doi: 10.1007/s10147-006-0583-4. Int J Clin Oncol. 2006. PMID: 16850125 Review.

10

Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib.

Kosaka T, Yatabe Y, Endoh H, Yoshida K, Hida T, Tsuboi M, Tada H, Kuwano H, Mitsudomi T. Kosaka T, et al. Clin Cancer Res. 2006 Oct 1;12(19):5764-9. doi: 10.1158/1078-0432.CCR-06-0714. Clin Cancer Res. 2006. PMID: 17020982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,255 results

Search Page